Drugs / S26E
last change Nov 2021 re-read 3 minutes ago

S26E

Developed for
ulcer of lower limbs
Investigated by
National and Kapodistrian University of Athens

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04186377 May 2020 → Nov 2021 ulcer of lower limbs National and Kapodistrian University of Athens Terminated No outcome recorded Stop: Enrollment

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as S26E ClinicalTrials.gov intervention name — accepted as the source's own label NCT04186377 ↗
Known as kalahari melon (Citrullus lanatus) seed oil “kalahari melon (Citrullus lanatus) seed oil (S26E)” NCT04186377 ↗
Route Topical “Daily application of S26E extract on wound site” NCT04186377 ↗